Table 1.

Patient baseline demographics and disease characteristics

CharacteristicN = 87
Median age, y (range)60 (36–83)
Male/female, n (%)44 (51)/43 (49)
Race, n (%)
 Caucasian75 (86)
 Black or African-American11 (13)
 Other1 (1)
Tumor type, n (%)
 Colorectal cancer15 (17)
 NSCLC10 (11)
 Ovarian cancer10 (11)
 Soft tissue sarcoma8 (9)
 Head and neck cancer6 (7)
 Othera38 (44)
 ECOG performance status 0/1, n (%)42 (48)/45 (52)
Prior therapies, n (%)
 Systemic therapy85 (98)
 Radiation49 (56)
 ≥3 prior systemic therapies, n (%)60 (69)
  • aAnal carcinoma (n = 3); breast cancer (n = 3); cervical carcinoma (n = 1); esophageal cancer (n = 1); gallbladder carcinoma (n = 2); intestinal cancer (n = 3); liver cancer (n = 1); mesothelioma (n = 2); pancreatic carcinoma (n = 4); prostate cancer (n = 4); skin cancer (n = 1); small cell lung cancer (n = 4); uterine carcinoma (n = 4); tumors of unknown origin (n = 5).